Abbott Laboratories Total Current Liabilities

Abbott Laboratories (ABT) currently reports a total current liabilities of $16B as of September 2026. That compares with $15B in the prior-year period — up 10.8% year over year. Use the charts on this page to explore Abbott Laboratories's total current liabilities history and peer comparisons.

Abbott Laboratories's total current liabilities increased from $15B to $16B — a 10.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abbott Laboratories reported $16B in total current liabilities as of September 2026. That compares with $15B in the prior-year period — up 10.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $16B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abbott Laboratories, and consider following ABT for alerts when major investors trade the stock.

Abbott Laboratories is classified in the Healthcare sector. On total current liabilities, it currently shows $16B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABT with unrelated industries.